Old Web
English
Sign In
Acemap
>
authorDetail
>
Christophe Le Corre
Christophe Le Corre
Novartis
Phases of clinical research
Panobinostat
Medicine
Refractory
Immunology
3
Papers
261
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study
2012
Journal of Clinical Oncology
Anas Younes
Anna Sureda
Dina Ben-Yehuda
Pier Luigi Zinzani
Tee Chuan Ong
H. Miles Prince
Simon J. Harrison
Mark Kirschbaum
Patrick Bruce Johnston
Jennifer Gallagher
Christophe Le Corre
Angela Shen
Andreas Engert
Show All
Source
Cite
Save
Citations (212)
Final Analysis: Phase II Study of Oral Panobinostat In Relapsed/Refractory Hodgkin Lymphoma Patients Following Autologous Hematopoietic Stem Cell Transplant
2010
Blood
Anna Sureda
Anas Younes
Dina Ben-Yehuda
Tee Chuan Ong
Jonathan L. Kaufman
Christophe Le Corre
Jennifer Gallagher
Angela Shen
Andreas Engert
Show All
Source
Cite
Save
Citations (27)
Efficacy of Panobinostat in Phase II Study in Patients with Relapsed/Refractory Hodgkin Lymphoma (HL) After High-Dose Chemotherapy with Autologous Stem Cell Transplant.
2009
Blood
Anas Younes
Tee Chuan Ong
Vincent Ribrag
Andreas Engert
Dina Ben-Yehuda
Robin McCabe
Angela Shen
Christophe Le Corre
Samit Hirawat
Anna Sureda
Show All
Source
Cite
Save
Citations (22)
1